Mutational Status Is Associated With Time to First Treatment in Newly Diagnosed CLL
October 21st 2021
The presence of at least 1 mutation captured by next-generation sequencing was associated with a shorter time to first treatment among patients with newly diagnosed chronic lymphocytic leukemia, particularly those with mutations in POT1, ATM, FBXW7, and MYD88 genes.